{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:38:43Z","timestamp":1775705923560,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaad.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:33:22Z","timestamp":1638995602000},"page":"684-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents"],"prefix":"10.1016","volume":"87","author":[{"given":"Mikael","family":"Horissian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Maczuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Zaenglein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2021.12.005_bib1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.14340","article-title":"Spironolactone in dermatology: uses in acne and beyond","volume":"45","author":"Searle","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.005_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systematic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.005_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/pde.14391","article-title":"Use of spironolactone to treat acne in adolescent females","volume":"38","author":"Roberts","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.12.005_bib4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/jdv.16302","article-title":"Treatment of acne with\u00a0spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007\u20132017","volume":"34","author":"Roberts","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.005_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2020.5468","article-title":"Temporal trends and clinician variability in potassium monitoring of healthy young women treated for acne with spironolactone","volume":"157","author":"Barbieri","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221029613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221029613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:06:28Z","timestamp":1759273588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221029613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0190962221029613"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.12.005","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}